A detailed history of D. E. Shaw & Co., Inc. transactions in Lemaitre Vascular Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 49,804 shares of LMAT stock, worth $4.83 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
49,804
Holding current value
$4.83 Million
% of portfolio
0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$80.3 - $92.89 $1.63 Million - $1.89 Million
20,329 Added 68.97%
49,804 $4.63 Million
Q2 2024

Aug 14, 2024

BUY
$62.62 - $83.59 $1.85 Million - $2.46 Million
29,475 New
29,475 $2.43 Million
Q4 2023

Feb 14, 2024

SELL
$45.37 - $58.41 $1.26 Million - $1.62 Million
-27,796 Reduced 75.28%
9,129 $518,000
Q3 2023

Nov 14, 2023

SELL
$53.45 - $67.01 $1.32 Million - $1.65 Million
-24,667 Reduced 40.05%
36,925 $2.01 Million
Q2 2023

Aug 14, 2023

BUY
$50.38 - $68.21 $3.1 Million - $4.2 Million
61,592 New
61,592 $4.14 Million
Q3 2021

Nov 15, 2021

SELL
$53.09 - $60.57 $245,222 - $279,772
-4,619 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$47.74 - $63.33 $668,932 - $887,379
-14,012 Reduced 75.21%
4,619 $282,000
Q1 2021

May 17, 2021

BUY
$40.19 - $51.5 $223,255 - $286,082
5,555 Added 42.48%
18,631 $909,000
Q4 2020

Feb 16, 2021

BUY
$31.44 - $41.27 $411,109 - $539,646
13,076 New
13,076 $530,000
Q4 2019

Feb 14, 2020

SELL
$31.27 - $36.21 $335,996 - $389,076
-10,745 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$27.91 - $35.78 $79,208 - $101,543
2,838 Added 35.89%
10,745 $367,000
Q2 2019

Aug 14, 2019

SELL
$25.55 - $30.79 $7,665 - $9,237
-300 Reduced 3.66%
7,907 $221,000
Q1 2019

May 15, 2019

BUY
$22.45 - $31.55 $184,247 - $258,930
8,207 New
8,207 $254,000

Others Institutions Holding LMAT

About LEMAITRE VASCULAR INC


  • Ticker LMAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 21,962,900
  • Market Cap $2.13B
  • Description
  • LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that tem...
More about LMAT
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.